[1]荆朝辉,荣晓松,焦国庆,等.合并重度肺动脉高压的二尖瓣疾病行二尖瓣
置换术的安全性[J].国际心血管病杂志,2024,01:62-64.
点击复制
合并重度肺动脉高压的二尖瓣疾病行二尖瓣
置换术的安全性(PDF)
《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]
- 期数:
- 2024年01期
- 页码:
- 62-64
- 栏目:
- 经验交流
- 出版日期:
- 2024-01-22
文章信息/Info
- Title:
- -
- Author(s):
- -
- Keywords:
- -
- 分类号:
- -
- DOI:
- 10.3969/j.issn.1673-6583.2024.01.017
- 文献标识码:
- -
- 摘要:
- 目的：探讨二尖瓣疾病合并重度肺动脉高压的患者行二尖瓣置换术的安全 性。 方法：回顾性纳入2005 年1 月至2023 年1 月南京医科大学附属无锡人民医院的 75 例二尖瓣疾病合并重度肺动脉高压患者。统计患者手术方式、体外循环时间、阻断 时间、死亡率、术后主要不良心血管事件发生情况，比较手术前后肺动脉压力、左房内 径、左室舒张末期内径、左室射血分数等参数的变化。 结果：75 例患者均行二尖瓣置换 术。随访3 个月无死亡、围手术期脑梗死、肾功能衰竭等发生。术后肺动脉压力较术前 明显下降[（85.2±15.7
- Abstract:
- -
参考文献/References
[1] Walls MC, Cimino N, Bolling SF, et al. Persistent pulmonary
hypertension after mitral valve surgery: does surgical procedure
affect outcome?[J]. Heart Valve Dis, 2008, 17(1):1-9.
[2] Roselli EE, Abdel Azim A, Houghtaling PL, et al. Pulmonary
hypertension is associated with worse early and late outcomes
after aortic valve replacement: implications for transcatheter
aortic valve replacement[J]. J Thorac Cardiovasc Surg, 2012,
144(5):1067-1074.
[3] Ben-Yehuda O, Shahim B, Chen S, et al. Pulmonary hypertension
in transcatheter mitral valve repair for secondary mitral
regurgitation: the COAPT trial[J]. J Am Coll Cardiol, 2020,
76(22):2595-2606.
[4] 熊长明. 《中国肺动脉高压诊断与治疗指南（2021版）》
解读——左心疾病所致肺动脉高压[J]. 中国实用内科杂志,
2022, 42(2):128-130.
[5] Najafi H, Dye WS, Javid H, et al. Mitral valve replacement.
Review of seven years' experience[J]. Am J Cardiol, 1969,
24(3):386-392.
[6] Cámara ML, Aris A, Padró JM, et al. Long-term results of mitral
valve surgery in patients with severe pulmonary hypertension[J].
Ann Thorac Surg, 1988, 45(2):133-136.
[7] Cesnjevar RA, Feyrer R, Walther F, et al. High-risk mitral
valve replacement in severe pulmonary hypertension-30 years
experience[J]. Eur J Cardiothorac Surg, 1998, 13(4):344-352.
[8] Ghoreishi M, Evans CF, DeFilippi CR, et al. Pulmonary
hypertension adversely affects short- and long-term survival
after mitral valve operation for mitral regurgitation: implications
for timing of surgery[J]. J Thorac Cardiovasc Surg, 2011,
142(6):1439-1452.
[9] Guerrero M, Urena M, Himbert D, et al. 1-year outcomes of
transcatheter mitral valve replacement in patients with severe
mitral annular calcification[J]. J Am Coll Cardiol, 2018,
71(17):1841-1853.
[10] Al-Bawardy R, Vemulapalli S, Thourani VH, et al. Association of
pulmonary hypertension with clinical outcomes of transcatheter
mitral valve repair[J]. JAMA Cardiol, 2020, 5(1):47-56.
[11] Muhammad ZK, Salman Z, Muhammad UK, et al. Comparison
of in-hospital outcomes of transcatheter mitral valve repair
in patients with vs without pulmonary hypertension(from the
national inpatient sample)[J]. Am J Cardiol, 2021,153:101-108.
[12] Hawkins RB, Strobel RJ, Mehaffey JH, et al. Pulmonary
hypertension and operative risk in mitral valve and coronary
surgery[J]. J Surg Res, 2023, 286:49-56.
[13] Song XC, Zhang C, Chen X, et al. An excellent result of surgical
treatment in patients with severe pulmonary arterial hypertension
following mitral valve disease[J]. J Cardiothorac Surg, 2015,
10:70.
[14] Enter DH, Zaki A, Duncan BF, et al. A contemporary analysis
of pulmonary hypertension in patients undergoing mitral valve
surgery: is this a risk factor?[J]. J Thorac Cardiovasc Surg, 2016,
151(5):1288-1297.
[15] Yang B, DeBenedictus C, Watt T, et al. The impact of
concomitant pulmonary hypertension on early and late outcomes
following surgery for mitral stenosis[J]. J Thorac Cardiovasc
Surg, 2016, 152(2):394-400.e1.
[16] Genuardi MV, Shpilsky D, Handen A, et al. Increased mortality
in patients with preoperative and persistent postoperative
pulmonary hypertension undergoing mitral valve surgery for
mitral regurgitation: a cohort study[J]. J Am Heart Assoc, 2021,
10(5):e018394.
备注/Memo
- 备注/Memo:
- 通信作者：荆朝辉， E-mail：fangyuan6699@hotmail.com
常用功能
统计/Statistics
- 摘要浏览/Viewed226
- 全文下载/Downloads305
- 评论/Comments
